Clark JR - Search Results

1

Prognostic significance of disease-free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases.

Ebrahimi A, Clark JR, Ahmadi N, Palme CE, Morgan GJ, Veness MJ. Ebrahimi A, et al. Among authors: clark jr. Head Neck. 2013 Aug;35(8):1138-43. doi: 10.1002/hed.23096. Epub 2012 Nov 14. Head Neck. 2013. PMID: 23152126

2

Analysis of prognostic factors in squamous cell carcinomas of the head and neck.

Dreyfuss AI, Clark JR. Dreyfuss AI, et al. Among authors: clark jr. Hematol Oncol Clin North Am. 1991 Aug;5(4):701-12. Hematol Oncol Clin North Am. 1991. PMID: 1890061 Review.

3

The role of cisplatin in treatment regimens for squamous cell carcinoma of the head and neck.

Clark JR, Dreyfuss AI. Clark JR, et al. Semin Oncol. 1991 Feb;18(1 Suppl 3):34-48. Semin Oncol. 1991. PMID: 2003226 Review.

4

Circulating immune complexes and chemotherapy response in patients with head and neck cancer.

Blazar BA, Fried MP, Strome M, Clark JR, Sereno P, Rodliff S, Caminear D. Blazar BA, et al. Among authors: clark jr. Head Neck. 1989 Sep-Oct;11(5):431-6. doi: 10.1002/hed.2880110509. Head Neck. 1989. PMID: 2807883

5

T-cell subsets and natural killer cell function with squamous cell carcinoma of the head and neck.

Strome M, Clark JR, Fried MP, Rodliff S, Blazar BA. Strome M, et al. Among authors: clark jr. Arch Otolaryngol Head Neck Surg. 1987 Oct;113(10):1090-3. doi: 10.1001/archotol.1987.01860100068024. Arch Otolaryngol Head Neck Surg. 1987. PMID: 3497652

6

Primary site management following induction chemotherapy with cis-platinum, 5-fluorouracil, and leucovorin.

Busse PM, Clark JR, Beard CJ, Dreyfuss AI, Lucarini JW, Rossi R, Casey D, Norris CM Jr. Busse PM, et al. Among authors: clark jr. Head Neck. 1993 Sep-Oct;15(5):413-8. doi: 10.1002/hed.2880150508. Head Neck. 1993. PMID: 8407313 Clinical Trial.

7

Docetaxel: an active drug for squamous cell carcinoma of the head and neck.

Dreyfuss AI, Clark JR, Norris CM, Rossi RM, Lucarini JW, Busse PM, Poulin MD, Thornhill L, Costello R, Posner MR. Dreyfuss AI, et al. Among authors: clark jr. J Clin Oncol. 1996 May;14(5):1672-8. doi: 10.1200/JCO.1996.14.5.1672. J Clin Oncol. 1996. PMID: 8622087 Clinical Trial.

8

Phase II study of N-phosphonacetyl-L-aspartate, recombinant interferon-alpha, and fluorouracil infusion in advanced squamous cell carcinoma of the head and neck.

Langer CJ, Schaebler D, Sauter E, DeMaria D, Johnson C, Reilly DM, Clark J, Leighton J, Aks C, Litwin S, Ridge JA. Langer CJ, et al. Head Neck. 1998 Aug;20(5):385-91. doi: 10.1002/(sici)1097-0347(199808)20:5<385::aid-hed5>3.0.co;2-u. Head Neck. 1998. PMID: 9663665 Clinical Trial.

9

Patterns of spread in recurrent head and neck squamous cell carcinoma.

Vaidya AM, Petruzzelli GJ, Clark J, Emami B. Vaidya AM, et al. Otolaryngol Head Neck Surg. 2001 Oct;125(4):393-6. doi: 10.1067/mhn.2001.117715. Otolaryngol Head Neck Surg. 2001. PMID: 11593178

10

Outcome of treatment for advanced cervical metastatic squamous cell carcinoma.

Clark J, Li W, Smith G, Shannon K, Clifford A, McNeil E, Gao K, Jackson M, Mo Tin M, O'Brien C. Clark J, et al. Head Neck. 2005 Feb;27(2):87-94. doi: 10.1002/hed.20129. Head Neck. 2005. PMID: 15627246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,506 results

Search Page

Filters